How does WXT compare to ChinaPeptides (QYAOBIO) on documentation quality?

What I have: WXT · ChinaPeptides (QYAOBIO).

I suspect the honest answer is that it depends, in which case I would like to know on what.

Assume I can obtain either option without difficulty, so availability is not the deciding factor.

Under what conditions does the answer flip?

Answering this needs the axis. A supplier that is best on paperwork and a supplier that is best on price are both correct answers to different questions.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

On the detail: lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.

The caveat is that a comparison is a snapshot of the lots compared, and lots change.

Use a fixed documentation checklist rather than an impression.

edited 11 Apr 2026 by p_mkhize — clarified the distinction between purity and content

On the detail: ratings on this site are ours alone and are deliberately not reconciled with anyone else's.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Concretely, cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

Price per milligram of measured peptide, not per milligram of label claim.

It helps to be literal here: a single member running three suppliers on one method is worth more than thirty members running one supplier each.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Name the laboratory and the dates or the comparison cannot be reproduced.

This is the question where methodology matters more than the conclusion.

Content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.

Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.

One laboratory, one method, one submission. Otherwise it is not a comparison.

edited 10 Feb 2026 by j_wierzbicki — expanded the table to cover the lower concentration